Novel mutations in the gene encoding ATP-binding cassette 1 in four tangier disease kindreds.

Tangier disease (TD) is an autosomal co-dominant disorder in which homozygotes have a marked deficiency of high density lipoprotein (HDL) cholesterol and, in some cases, peripheral neuropathy and premature coronary heart disease (CHD). Homozygotes are further characterized by cholesteryl ester deposition in various tissues throughout the body, most notably in those of the reticuloendothelial system. Several studies have demonstrated that the excess lipid deposition in TD is due to defective apolipoprotein-mediated efflux of cellular cholesterol and phospholipids. Although much progress has been made in our understanding of the metabolic basis of TD, the precise molecular defect had remained elusive until very recently. By positional cloning methods, we: 1) confirm the assignment of TD to chromosome 9q31, 2) provide evidence that human ATP-binding cassette-1 (hABC-1) maps to a 250 kb region on 9q31, and 3) describe novel deletion, insertion, and missense mutations in the gene encoding hABC-1 in four unrelated TD kindreds. These results establish a causal role for mutations in hABC-1 in TD and indicate that this transporter has a critical function in the regulation of intracellular lipid trafficking that dramatically affects plasma HDL cholesterol levels.

[1]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[2]  P. Denéfle,et al.  Human ATP-binding cassette transporter 1 (ABC1): genomic organization and identification of the genetic defect in the original Tangier disease kindred. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[3]  A. Vaughan,et al.  The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway. , 1999, The Journal of clinical investigation.

[4]  J. Piette,et al.  Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1 , 1999, Nature Genetics.

[5]  T. Langmann,et al.  The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease , 1999, Nature Genetics.

[6]  C. Sensen,et al.  Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency , 1999, Nature Genetics.

[7]  T. Langmann,et al.  Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophages. , 1999, Biochemical and biophysical research communications.

[8]  G. Assmann,et al.  Assignment of Tangier disease to chromosome 9q31 by a graphical linkage exclusion strategy , 1998, Nature Genetics.

[9]  E. Schneider,et al.  ATP-binding-cassette (ABC) transport systems: functional and structural aspects of the ATP-hydrolyzing subunits/domains. , 1998, FEMS microbiology reviews.

[10]  M. Freeman,et al.  Decreased cholesterol efflux from fibroblasts of a patient without Tangier disease, but with markedly reduced high density lipoprotein cholesterol levels. , 1998, The Journal of clinical endocrinology and metabolism.

[11]  G. Torpier,et al.  High-density-lipoprotein subfraction 3 interaction with glycosylphosphatidylinositol-anchored proteins. , 1997, The Biochemical journal.

[12]  H. Brewer,et al.  Decreased reverse cholesterol transport from Tangier disease fibroblasts. Acceptor specificity and effect of brefeldin on lipid efflux. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[13]  K. Simons,et al.  Caveolae, DIGs, and the dynamics of sphingolipid-cholesterol microdomains. , 1997, Current opinion in cell biology.

[14]  B. Verrier,et al.  ABC1, an ATP Binding Cassette Transporter Required for Phagocytosis of Apoptotic Cells, Generates a Regulated Anion Flux after Expression in Xenopus laevis Oocytes* , 1997, The Journal of Biological Chemistry.

[15]  A. Mendez,et al.  Apolipoprotein-mediated cellular cholesterol and phospholipid efflux depend on a functional Golgi apparatus. , 1996, Journal of lipid research.

[16]  G. Assmann,et al.  Defective regulation of phosphatidylcholine-specific phospholipases C and D in a kindred with Tangier disease. Evidence for the involvement of phosphatidylcholine breakdown in HDL-mediated cholesterol efflux mechanisms. , 1996, The Journal of clinical investigation.

[17]  Piet Borst,et al.  MDR1 P-Glycoprotein Is a Lipid Translocase of Broad Specificity, While MDR3 P-Glycoprotein Specifically Translocates Phosphatidylcholine , 1996, Cell.

[18]  K Lange,et al.  Descent graphs in pedigree analysis: applications to haplotyping, location scores, and marker-sharing statistics. , 1996, American journal of human genetics.

[19]  P. Pedersen,et al.  The First Nucleotide Binding Fold of the Cystic Fibrosis Transmembrane Conductance Regulator Can Function as an Active ATPase (*) , 1995, The Journal of Biological Chemistry.

[20]  C. Higgins,et al.  The ABC of channel regulation , 1995, Cell.

[21]  G. Schmitz,et al.  Activation of phosphatidylinositol-specific phospholipase C in response to HDL3 and LDL is markedly reduced in cultured fibroblasts from Tangier patients. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[22]  G. Francis,et al.  Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier Disease. , 1995, The Journal of clinical investigation.

[23]  G. Rogler,et al.  HDL-mediated efflux of intracellular cholesterol is impaired in fibroblasts from Tangier disease patients. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[24]  J. Bryan,et al.  Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy. , 1995, Science.

[25]  G. Assmann,et al.  The high density lipoprotein- and apolipoprotein A-I-induced mobilization of cellular cholesterol is impaired in fibroblasts from Tangier disease subjects. , 1994, Biochemical and biophysical research communications.

[26]  R. Lees,et al.  Homozygous Tangier disease and cardiovascular disease. , 1994, Atherosclerosis.

[27]  P. Wilson,et al.  Factors associated with low and elevated plasma high density lipoprotein cholesterol and apolipoprotein A-I levels in the Framingham Offspring Study. , 1994, Journal of lipid research.

[28]  F. Denizot,et al.  Cloning of two novel ABC transporters mapping on human chromosome 9. , 1994, Genomics.

[29]  V. Ling,et al.  ATPase activity of purified and reconstituted P-glycoprotein from Chinese hamster ovary cells. , 1994, The Journal of biological chemistry.

[30]  M. Welsh,et al.  Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis , 1993, Cell.

[31]  C. Higgins,et al.  ABC transporters: from microorganisms to man. , 1992, Annual review of cell biology.

[32]  C. Higgins,et al.  Separation of drug transport and chloride channel functions of the human multidrug resistance P-glycoprotein , 1992, Cell.

[33]  P. Greengard,et al.  Phosphorylation of the cystic fibrosis transmembrane conductance regulator. , 1992, The Journal of biological chemistry.

[34]  R. Boucher,et al.  Biochemical characterization of the cystic fibrosis transmembrane conductance regulator in normal and cystic fibrosis epithelial cells. , 1992, The Journal of biological chemistry.

[35]  A. Garner,et al.  The cornea in familial high density lipoprotein deficiency, tangier disease , 1991 .

[36]  A. Mendez,et al.  Protein kinase C as a mediator of high density lipoprotein receptor-dependent efflux of intracellular cholesterol. , 1991, The Journal of biological chemistry.

[37]  G. Ames,et al.  The membrane-bound proteins of periplasmic permeases form a complex. Identification of the histidine permease HisQMP complex. , 1991, The Journal of biological chemistry.

[38]  J. Slotte,et al.  High density lipoprotein apolipoproteins mediate removal of sterol from intracellular pools but not from plasma membranes of cholesterol-loaded fibroblasts. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[39]  G. Schmitz,et al.  Dysregulation of lipid metabolism in Tangier monocyte-derived macrophages. , 1990, Arteriosclerosis.

[40]  S. Akiyama,et al.  Cytoplasmic orientation and two-domain structure of the multidrug transporter, P-glycoprotein, demonstrated with sequence-specific antibodies. , 1989, The Journal of biological chemistry.

[41]  J. Breslow,et al.  Sequence and expression of Tangier apoA-I gene. , 1988, European journal of biochemistry.

[42]  R. Gregg,et al.  In vivo metabolism of proapolipoprotein A-I in Tangier disease. , 1987, The Journal of clinical investigation.

[43]  H. Brewer,et al.  Tangier disease. The complete mRNA sequence encoding for preproapo-A-I. , 1985, The Journal of biological chemistry.

[44]  J. Ott,et al.  Multilocus linkage analysis in humans: detection of linkage and estimation of recombination. , 1985, American journal of human genetics.

[45]  E. Schaefer Clinical, biochemical, and genetic features in familial disorders of high density lipoprotein deficiency. , 1984, Arteriosclerosis.

[46]  J. Albers,et al.  Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. , 1982, Clinical chemistry.

[47]  H. Brewer,et al.  Metabolism of high density lipoprotein subfractions and constituents in Tangier disease following the infusion of high density lipoproteins. , 1981, Journal of lipid research.

[48]  H. Brewer,et al.  Coronary heart disease prevalence and other clinical features in familial high-density lipoprotein deficiency (Tangier disease). , 1980, Annals of internal medicine.

[49]  C. Blum,et al.  Metabolism of high-density lipoprotein apolipoproteins in Tangier disease. , 1978, The New England journal of medicine.

[50]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[51]  P. Wilson,et al.  Reference intervals for plasma apolipoprotein B determined with a standardized commercial immunoturbidimetric assay: results from the Framingham Offspring Study. , 1996, Clinical chemistry.

[52]  Ion Channels and Genetic Diseases. Proceedings of the Society of General Physiologists 48th Annual Symposium. Woods Hole, Massachusetts, 7-11 September 1994. , 1995, Society of General Physiologists series.

[53]  I. Pastan,et al.  Biochemistry of multidrug resistance mediated by the multidrug transporter. , 1993, Annual review of biochemistry.

[54]  M. Boehnke,et al.  Allele frequency estimation from data on relatives. , 1991, American journal of human genetics.

[55]  L. Tsui,et al.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. , 1989, Science.

[56]  G. Assmann,et al.  Interaction of Tangier lipoproteins with cholesteryl ester-laden mouse peritoneal macrophages. , 1987, Journal of lipid research.